KYAN invited to present at AI Pharma Innovation Summit

7.26.17 (Boston, MA). KYAN's Chief Technology and Co-Founder, Chih-Ming Ho (Member, US National Academy of Engineering), will join the world's leading pharmaceutical companies to present KYAN's latest advances at the AI Pharma Innovation Summit. More information can be found at: http://ai-pharma.com/about/

 

 

KYAN Chief Dean Ho named to the 2016 Power List in Pathologist Magazine

https://thepathologist.com/power-list/2016/

Power List.png

 

Technology developed by KYAN founders featured on the Cover of Science Translational Medicine

4.6.16 (Los Angeles, CA). A landmark advance in personalized and precision medicine was unveiled with a publication by KYAN co-founders Drs. Dean Ho and Chih-Ming Ho. Featured as the cover article of the April 6th issue of Science Translational Medicine (AAAS), this work actionably optimized post-liver transplant immunosuppression for the entire duration of treatment. (http://stm.sciencemag.org/content/8/333/333ra49). This was achieved without the use of algorithms or predictive modeling. Furthermore, the technology platform at the foundation of this study was mechanism-independent and indication agnostic, making it applicable towards every patient and every disease.

#PersonalizedMedicineForAll.

KYAN co-founder Dr. Dean Ho to speak at XPRIZE event

3.8.16 (Los Angeles, CA). Dean Ho, KYAN Co-Founder, will serve on the XPRIZE-Future of Medicine panel moderated by XPRIZE CEO Dr. Peter Diamandis. Dr. Ho will be joined by Craig Venter, renowned geneticist and CEO of Human Longevity, Inc., and Nick Desai, CEO of Heal. More information can be found at: http://futurizex.ucla.edu/speaker-series/

XPRIZE website.png

 

KYAN co-founder Dr. Dean Ho completes term as President, SLAS Board of Directors

1.23.16 (San Diego, CA) Dr. Dean Ho, KYAN Co-Founder, recently opened the Annual Conference of the Society for Laboratory Automation (SLAS), a leading technology event for the pharmaceutical, diagnostics, and drug screening industry and academic space with over 6000 attendees. At SLAS2016, Dr. Ho completed his term as the President of the Board of Directors which is comprised of visionaries at the intersection of drug development and medical technology.

 

KYAN co-founder Dr. Dean Ho featured in The Economist

10.31.15 (London, England) Dr. Dean Ho, KYAN Co-Founder, was recently featured in The Economist. Dr. Ho was highlighted for his development of a nanotechnology-enhanced biomaterial to improve outcomes in oral surgery. More information can be found at: http://www.economist.com/news/science-and-technology/21677190-adding-tiny-gems-may-make-root-canal-treatment-more-effective-tooth-fairy-dust

 

KYAN co-founder Dr. Dean Ho elected to the American Institute of Medical and Biological Engineering

3.5.15. (Washington, DC) Dr. Dean Ho, KYAN Co-Founder, was recently elected to the College of Fellows of the American Institute of Medical and Biological Engineering (AIMBE). Election is based on nomination and voting by current AIMBE Fellows, membership is reserved for the top 2% of bioengineers in the field.

 

KYAN co-founder Dr. Chih-Ming Ho receives honorary doctorate from HKUST

7.11.14 (Hong Kong) Dr. Chih-Ming Ho, KYAN Co-Founder, was awarded an honorary doctorate (Doctorate of Engineering honoris causa) from the Hong Kong University of Science and Technology for his distinguished achievements and contributions. More information can be found in the university press release: http://www.ust.hk/about-hkust/media-relations/press-releases/22nd-cong-2/

 

KYAN co-founder Dr. Chih-Ming Ho elected to the American Institute of Medical and Biological Engineering

5.22.14 (Washington, DC) Dr. Chih-Ming Ho, KYAN Co-Founder, was recently elected to the College of Fellows of the American Institute of Medical and Biological Engineering (AIMBE). Election is based on nomination and voting by current AIMBE Fellows, membership is reserved for the top 2% of bioengineers in the field.